Protocol Design Featured Articles

  1. Takeda's Diversity Strategy Pays Off For Phase 3 Trial 3/12/2025

    LaShell Robinson, head of global feasibility and trial equity at Takeda explains how the company’s Phase 3 trial for a psoriasis drug ended enrollment well before it’s goal and achieved some impressive diversity metrics. 

  2. Social Media And A Site-Less Model Led This Trial To Pandemic-Era Success 3/10/2025

    Genescopy's Chief Science and Medical Officer Erica Barnell, MD, Ph.D. explains how social media recruiting and a site-less trial design helped the company's CRC-PREVENT Phase 3 trial succeed.

  3. Bridging Clinical Research And Care With TransCelerate's Rob DiCicco 3/7/2025

    TransCelerate's Rob DiCicco offers insights into why bridging clinical care and research matters and the challenges that must be overcome to realize the vision.

  4. Lessons Learned From Vivani Medical's Study Of GLP-1 Implant 3/5/2025

    Vivani Medical Cofounder and CEO Adam Mendelsohn, Ph.D. discusses the company’s first application of the NanoPortal, including its upsides for patient adherence, its optimized trial design,  and its reception among sites and patients.

  5. 4 Crucial Differences Between Early-Phase And Late-Phase Trial Site Selection 2/28/2025

    Learn the differences between early-phase and late-phase trial site selection, including what makes an ideal site for early-phase trials, where speed, precision, and adaptability are non-negotiable.

  6. Understanding Lupus Trial Participation And The Importance Of Patient Support 2/27/2025

    Lupus Therapeutics Director of Patient Engagement Caroline Donovan explores the challenges of patient enrollment and heralds the role of patient support in running successful trials for lupus patients.

  7. Day One Bio's Talks With FDA Help Secure Glioma Drug Approval 2/14/2025

    Day One CMO Elly Barry, MD recounts the company's experience working with the FDA and turning a passed-over drug into its first-ever approved treatment for pediatric glioma patients.

  8. Harness MDIC's Collaborative Resources to Strengthen Clinical Trials and Patient Outcomes 2/13/2025

    Discover how resources from the Medical Device Innovation Consortium (MDIC) can help advance clinical trials for better patient outcomes.

  9. Roche Diagnostics Guides New Alzheimer's Test Through Trials 2/12/2025

    Roche Diagnostics’ Maria-Magdelena Patru, MD, PhD discusses their plasma test and how they’re approaching its clinical trials. 

  10. How PDS Biotech Approached FDA Meetings For Its Phase 3 Cancer Trial 2/11/2025

    PDS Biotech CMO Kirk Shepard reveals his team’s interactions with the FDA as it sought to begin its Phase 3 trial for the treatment of HPV-positive recurrent and/or metastatic head and neck squamous cell carcinoma.